China VC Weekly: Risk Management, Medicine and Architectural Tech
In this week’s China VC news, AI risk management solutions provider Ice Kredit raises a 228 million yuan Series C2 round, cancer and immune disorder treatment developer Innolake Biopharm bags $46 million to speed up R&D, while RoboticPlus.AI receives $20 million from BAI and C Ventures.
AI risk manager Ice Kredit bags 228 million …
Keep reading with a 7-day free trial
Subscribe to Pandaily to keep reading this post and get 7 days of free access to the full post archives.